Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD201 Rat anti-Human, Alexa Fluor 488, Clone: RCR-252, BD

Rat Monoclonal Antibody

Supplier:  BD Biosciences 563623

Catalog No. BDB563623

Item Discontinued This item has been discontinued by Fisher Scientific. Please to view product availability in your area.


Description

Description

The RCR-252 monoclonal antibody specifically binds to the endothelial cell protein C receptor (EPCR), which is also known as CD201. CD201 is a 25 kDa, type I transmembrane glycoprotein, expressed on endothelial cells in arteries, veins and capillaries. CD201 binds activated protein C, a serine protease that is involved in regulating blood coagulation. EPCR is reportedly expressed on several malignant cell lines. Malignant cell lines that express EPCR can show significant levels of protein C activation and this activation can be inhibited by anti-EPCR antibody

TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD201
Monoclonal
Alexa Fluor 488
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
EPCR-positive RE-1 Cells
100 Tests
Primary
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Flow Cytometry
RCR-252
EPCR; Activated protein C receptor; APC receptor; PROCR; centrocyclin
Rat
Affinity Purified
RUO
Human
IgG1 κ
Product Suggestions

Product Suggestions

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit